Quick Answer
CalciMedica, Inc. reported Stockholders Equity of -$6.64 million for the year ending 2025.
- CalciMedica, Inc. showed a decrease of -146.1% in Stockholders Equity from 2024 to 2025.
- This data is from CalciMedica, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$72.92 million | Q2 2019: -$83.04 million | Q3 2019: -$92.87 million | Q1 2020: -$110.51 million | Q2 2020: -$116.16 million | Q3 2020: $90.63 million | Q1 2021: $84.56 million | Q2 2021: $78.67 million | Q3 2021: $72.14 million | Q1 2022: -$67.28 million | Q2 2022: -$69.97 million | Q3 2022: -$71.79 million | Q1 2023: $22.02 million | Q2 2023: $16.22 million | Q3 2023: $12.16 million | Q1 2024: $17.25 million | Q2 2024: $13.84 million | Q3 2024: $9.03 million | Q1 2025: $10.89 million | Q2 2025: $6.10 million | Q3 2025: -$268.0 thousand.
- Over the full 8 years of available data (2018 to 2025), CalciMedica, Inc.'s Stockholders Equity has grown by 90.1%.
- Historical annual values: Fiscal year 2025: -$6.64 million | Fiscal year 2024: $14.41 million | Fiscal year 2023: $8.16 million | Fiscal year 2022: -$71.30 million | Fiscal year 2021: -$63.99 million | Fiscal year 2020: $94.79 million | Fiscal year 2019: -$102.95 million | Fiscal year 2018: -$66.79 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: